Home » Topics » Regulatory » Patents

Patents
RSS

Takeda presents new histamine H3 receptor antagonists

Aug. 3, 2011

Sanofi discloses novel protein kinase inhibitors

Aug. 3, 2011

Bristol-Myers Squibb synthesizes novel HCV NS5A inhibitors

Aug. 2, 2011

New GLP-1 analogues and derivatives disclosed by Novo Nordisk

Aug. 2, 2011

Novel c-Akt inhibitors synthesized at ArQule

Aug. 2, 2011

Poxel discloses new AMPK activators

Aug. 2, 2011

Merck KGaA presents novel sphingosine kinase 1 inhibitors

Aug. 2, 2011

New histamine H3 receptor antagonists prepared at Takeda

Aug. 2, 2011

Scynexis synthesizes new agents for hepatitis C

Aug. 1, 2011

Novel metabotropic glutamate mGlu5 receptor agonists reported

Aug. 1, 2011

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...